These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1877654)

  • 41. Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys.
    Gulbins E; Hoffend J; Zou AP; Dietrich MS; Schlottmann K; Cavarape A; Steinhausen M
    J Physiol; 1993 Sep; 469():571-82. PubMed ID: 8271216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
    Schlaich MP; Schmitt D; Ott C; Schmidt BM; Schmieder RE
    J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin.
    Kaufmann MA; Castelli I; Pargger H; Drop LJ
    J Pharmacol Exp Ther; 1995 May; 273(2):855-62. PubMed ID: 7752090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal hemodynamics in acute unilateral ureteral obstruction: contribution of endothelium-derived relaxing factor.
    Lanzone JA; Gulmi FA; Chou SY; Mooppan UM; Kim H
    J Urol; 1995 Jun; 153(6):2055-9. PubMed ID: 7752393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN; Nielsen CB; Pedersen EB
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
    Naess PA; Kirkebøen KA; Christensen G; Kiil F
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F939-42. PubMed ID: 1535755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of arteriolar tone and responses via L-arginine pathway in skeletal muscle.
    Kaley G; Koller A; Rodenburg JM; Messina EJ; Wolin MS
    Am J Physiol; 1992 Apr; 262(4 Pt 2):H987-92. PubMed ID: 1566917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation.
    Faraci FM
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1038-42. PubMed ID: 1928387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of endothelium-derived nitric oxide on cerebral circulation during normoxia and hypoxia in the rat.
    Koźniewska E; Oseka M; Styś T
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):311-7. PubMed ID: 1548305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelium-derived nitric oxide reduces baseline venous tone in awake instrumented rats.
    Glick MR; Gehman JD; Gascho JA
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H47-51. PubMed ID: 8102035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons.
    Nath KA; Chmielewski DH; Hostetter TH
    Am J Physiol; 1987 May; 252(5 Pt 2):F829-37. PubMed ID: 3578532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
    Narita I; Border WA; Ketteler M; Noble NA
    Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans.
    Wilson JR; Kapoor S
    J Appl Physiol (1985); 1993 Dec; 75(6):2740-4. PubMed ID: 8125898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelium-derived relaxing factor and the vascular reply to systemic hypertension.
    King AJ; Mercer P; Troy JL; Brenner BM
    J Am Soc Nephrol; 1991 Dec; 2(6):1072-7. PubMed ID: 1777587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of N-substituted arginine compounds on blood pressure in anesthetized rats.
    Thomas G; Myers A; Farhat M; Cathapermal S; Ramwell PW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):875-8. PubMed ID: 1602391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation.
    Hoffend J; Cavarape A; Endlich K; Steinhausen M
    Am J Physiol; 1993 Aug; 265(2 Pt 2):F285-92. PubMed ID: 8368337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat.
    Blantz RC; Konnen KS; Tucker BJ
    J Clin Invest; 1976 Feb; 57(2):419-34. PubMed ID: 1254727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat.
    Tanaka K; Gotoh F; Gomi S; Takashima S; Mihara B; Shirai T; Nogawa S; Nagata E
    Neurosci Lett; 1991 Jun; 127(1):129-32. PubMed ID: 1881609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
    Siragy HM; Johns RA; Peach MJ; Carey RM
    Hypertension; 1992 Jun; 19(6 Pt 2):775-9. PubMed ID: 1317356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.